Loading
Latest filing published 12 Jul 2016 for Celator Pharmaceuticals Inc, €28.4M.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Valence Life Sciences GP II LLC in Celator Pharmaceuticals Inc. The record holds 13 filings, for trades running from 10 February 2014 to 12 July 2016.
On the market, this insider has only ever bought: 5 purchases, €18k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
A typical purchase (the median) is worth €3,008.
On 12 July 2016 came the latest disclosure, a transaction for €28.4M in Celator Pharmaceuticals Inc. The clock since the last published purchase (2 October 2015) now reads 4,040 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations